Novartis drug Zortress® is first in over a decade approved by FDA to prevent organ rejection in adult liver transplant patients

Novartis drug Zortress® is first in over a decade approved by FDA to prevent organ rejection in adult liver transplant patients

Feb 15, 2013
Source URL: https://qa1.novartis.us/us-en/news/media-releases/novartis-drug-zortress-first-over-decade-approved-fda-prevent-organ-rejection-adult-liver-transplant-patients-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/novartis-drug-zortress-first-over-decade-approved-fda-prevent-organ-rejection-adult-liver-transplant-patients-0